ABSTRACT
Introducción: la Rinosinusitis Crónica se define como la inflamación crónica de la nariz y los senos paranasales por más de 12 semanas. La prevalencia varía entre el 5% - 30% de acuerdo con la zona geográfica según un estudio de carga de enfermedad (2012-2014), la prevalencia de las enfermedades respiratorias crónicas (rinitis y sinusitis crónica) varió entre el 10% y el 25%. Objetivo: establecer un conjunto de consideraciones basadas en consenso de expertos, para el diagnóstico y el tratamiento de la rinosinusitis crónica en pacientes adultos, en el contexto colombiano. Métodos: se llevó a cabo un consenso formal (Delphi y nominal). Se conformó un grupo de expertos, se definieron el alcance y las preguntas. Se realizaron dos rondas de calificación anónimas, y una discusión para las preguntas sin consenso. En las preguntas con opciones de uno a nueve, se consideró consenso con una mediana de uno a tres o de siete a nueve. En las preguntas tipo Likert, se consideró consenso un porcentaje igual o superior al 80% en acuerdos o desacuerdos. Resultados: se definieron y calificaron 18 preguntas, con la participación de 17 otorrinolaringólogos, de 8 ciudades colombianas, todos miembros de la Asociación Colombiana de Otorrinolaringología y con un promedio de experticia de 19.2 años (Desviación estándar [DE]: 10,2). Se obtuvieron 18 recomendaciones para el diagnóstico y el tratamiento de esta patología. Conclusiones: las recomendaciones emitidas por los expertos permiten orientar y estandarizar el diagnóstico y el tratamiento de la rinosinusitis crónica en adultos, en el contexto de los servicios de salud en Colombia.
Introduction: Chronic Rhinosinusitis is defined as chronic inflammation of the nose and paranasal sinuses for more than 12 weeks. The prevalence varies between 5% - 30% depending on the geographical area according to a disease burden study (2012-2014), the prevalence of chronic respiratory diseases (rhinitis and chronic sinusitis) varied between 10% - 25%. Objective: To establish a set of considerations based on expert consensus, for the diagnosis and treatment of chronic rhinosinusitis in adult patients, in the Colombian context. Methods: A formal consensus (Delphi and nominal) was carried out. A group of experts was formed, the scope and questions were defined. Two anonymous grading rounds were conducted, and a discussion for questions without consensus. In the Questions with options from one to nine were considered consensus with a median of one to three or seven to nine. In the Likert-type questions, a percentage equal to or greater than 80% in agreements or disagreements was considered consensus. Results: 18 questions were defined and scored, with the participation of 17 otorhinolaryngologists, from eight Colombian cities, all members of the Colombian Association of Otorhinolaryngology and with an average experience of 19.2 years (Standard desviation [SD]: 10.2). 18 recommendations were obtained for the diagnosis and treatment of this pathology. Conclusions: The recommendations issued by the experts allow to guide and standardize the diagnosis and treatment of chronic rhinosinusitis in adults, in the context of health services in Colombia.
Subject(s)
Humans , Sinusitis , Therapeutics , DiagnosisABSTRACT
@#BACKGROUND. Chronic rhino-sinusitis (CRS) is a common inflammatory disease of the nose and paranasal sinuses, especially after virus infections. It has a significant impact on patients’ quality of life. We aimed to evaluate the clinical value of low-level laser therapy (LLLT) forpediatric chronic rhino-sinusitis. METHODS. 30 patients 6-15 years old with CRS were divided into two groups: T1 were treated twice a week and T2 were treated five times a week for 2 treatment sessions within 2 weeks. Laser irradiation was delivered on 12 points over each maxillary and frontal sinuses with 30 seconds and the total treatment duration was 180 seconds. The evaluation was performed by a total symptom score based on SNOT-22 questionnaires of pre and after treatments. RESULTS. The total symptom scoreimproved significantly (p<0.15) in 27 cases. CONCLUSION. This study indicates that LLLT applied for 4 weeks improves symptoms in patients with CRS. LLLT is one of the most cost-efficient and painless treatment methods for pediatric rhino-sinusitis.
ABSTRACT
The association of fungus in allergic fungal rhino sinusitis has been around 200 times in the world literature. As per the available literature, the most common agent identified so far appears to be ASPERGILLUS, though the condition is increasingly associated with Dematiaceous fungi. Here we report for the first time the presence of unusual fungus in allergic rhino sinusitis, which has not been reported so far.
ABSTRACT
Introducción: La rinosinusitis, corresponde a un grupo de desórdenes que se caracteriza por la inflamación de la mucosa tanto de cavidades paranasales (CPN) como de fosas nasales. Está determinada por factores del huésped y ambientales que interactúan causando un estado inflamatorio persistente que produce remodelación de la mucosa. Entre éstos se destacan la alergia y otras alteraciones inmunológicas junto con la colonización por agentes infecciosos. Objetivo: Determinar las características demográficas, clínicas, inmunológicas y agentes infecciosos involucrados en la rinosinusitis crónica (RSC) y rinosinusitis aguda (RSA) recurrente de niños y adolescentes sometidos a cirugía endoscópica funcional (CEF). Establecer las posibles asociaciones de estas características con la necesidad de reoperación y la recurrencia de la enfermedad. Material y método: Estudio retrospectivo observacional en que se evalúan 28 niños y adolescentes sometidos a CEF en el servicio de ORL de Clínica Las Condes durante los años 2000 a 2009. Todos los pacientes contaban con estudio inmunológico y test cutáneo preoperatorio más biopsia de mucosa de CPN y cultivos intraoperatorios de secreción de CPN. Los análisis estadísticos se realizaron con test de Anova para los análisis descriptivos y para el análisis de grupos el test de Fisher. Considerando como significativo un p <0,05. Resultados: Se analizaron 28 pacientes; el 89,2 por ciento tuvo test cutáneo positivo y biopsia inflamatoria crónica eosinofílica (53,6(0) por ciento). El 17 por ciento presentó algún tipo de deficiencia inmunológica. Se obtuvo cultivos positivos intraoperatorios en el 71 por ciento de las muestras, en su mayoría agentes aeróbicos (57,1 por ciento), con 14,2 por ciento de anaerobios y sin presencia de hongos. Veinte y siete pacientes tuvieron seguimiento posoperatorio de 5 años. Cuatro de ellos (14 por ciento) debió ser reoperado...
Introduction: Rhino sinusitis is a group of disorders characterized by inflammation of the mucosa of both sinuses and nostrils. It is determined by environmental and host factors that interact causing a persistent inflammatory condition that causes remodeling of the mucosa. Chief among these are allergy and other immune disorders with colonization by infectious agents. Aim: To determine the demographic, clinical, immunologic and infectious agents involved in chronic Rhino sinusitis (CRS) and Recurrent Acute Rhino sinusitis (RAR) in children and adolescents undergoing functional endoscopic sinus surgery (FESS). Establish the possible associations of these characteristics with the need for re operation and recurrence of the disease. Material and method: Retrospective observational study that evaluated 28 children and adolescents involved in the ENT department at Clínica Las Condes, Santiago, Chile during the years 2000 to 2009. All study patients had preoperative Prick test, immune workout and intraoperative Para nasal mucosal biopsy and cultures of Para nasal secretion. Statistical analysis was performed using ANOVA test for descriptive analysis and cluster analysis with Fisher Exact test. Results were considered significant with p <0.05 Results: We analyzed 28 patients, 89.2 percent had positive Prick test and 53.6 percent showed biopsy with eosinophilic inflammatory disease. 17 percent had some type of immune deficiency. Positive intraoperative cultures were obtained in 71 percent of the samples, mostly aerobic agents (57.1 percent), with 14.2 percent anaerobes and negatives cultures for fungi. Twenty seven patients had postoperative follow-up of 5 years. Four of them (14 percent) had to be re-operated. During the monitoring period, 22 percent developed RAR. It was considered a poor surgical outcome the need for re-operation or recurrence of RAR. We couldn't find association of variables with a poor outcome after surgery...
Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Endoscopy , Rhinitis/surgery , Sinusitis/surgery , Retrospective Studies , Follow-Up Studies , Skin Tests , Recurrence , Reoperation , Rhinitis/immunology , Rhinitis/microbiology , Sinusitis/immunology , Sinusitis/microbiology , Bacteriological TechniquesABSTRACT
La rinosinusitis es una infección común en la población pediátrica, y entre sus complicaciones está la infección intracraneal que se relaciona con alta morbilidad y mortalidad. Es imprescindible un alto índice de sospecha para llegar así al diagnóstico temprano y brindar el tratamiento antibiótico y quirúrgico necesario. Presentamos nuestra experiencia de tres pacientes pediátricos con infección intracraneal secundaria a rinosinusitis.
Rhinosinusitis is a common infection in children and can present with intracranial complications associated with high morbidity and mortality. A high index of suspicion is essential to reach an early diagnosis, confirming it with imaging studies and initiating appropriate antibiotic and surgical treatment. Herein our experience with three pediatric patients with intracranial infection as a result of acute sinus infection has been presented.
Subject(s)
Humans , Male , Child, Preschool , Child , Adolescent , Sinusitis , Empyema, Subdural , Central Nervous System Infections , Rhinitis , Patient Care Management , Patient Care/methodsABSTRACT
BACKGROUND: Chronic rhino-sinusitis and persistent allergic rhinitis is often cited as risk factor for developing adenoid hypertrophy or adenoiditis, but this relationship has not been studied extensively. In this study, we evaluated the mucosal barrier, squamous changes of ciliated epithelium, IgA secretion and BCL-6 expression in adenoids, and adenoid size. METHODS: Six children with allergic rhinitis and sinusitis, nine children with only allergic rhinitis, nine children with only sinusitis and six children without any history of allergic rhinitis and sinusitis were enrolled. H-E stain of adenoid for squamous metaplasia, immunohistochemical study of adenoid for IgA and BCL-6, cytokeratin stain for evaluation of mucosal barrier and lateral view X-ray for adenoid size were performed. ANOVA test was used in the analysis and data showing p value of less than 0.05 were considered significant. RESULTS: The number of ciliated cells had tendency to be decreased and squamous metaplasia had tendency to be increased in three experimental groups (p>0.05). Deterioration of mucosal barrier had tendency to be detected in three experimental groups than control group (p>0.05). BCL-6 had tendency to be increased and IgA secretion had tendency to be decreased in three experimental groups (p>0.05). There is no difference in adenoid size between three experimental groups and control group. CONCLUSION: Despite the expectation that adenoid would be affectecd by allergic rhinitis and rhino-sinusitis, we found no evidence for influence of adenoid immunity.
Subject(s)
Child , Humans , Adenoids , Epithelium , Hypertrophy , Immunoglobulin A , Keratins , Metaplasia , Rhinitis , Risk Factors , SinusitisABSTRACT
BACKGROUND AND OBJECTIVE: The cysteinyl leukotrienes are bioactive lipid mediators that contribute to the pathophysiologic condition of asthma and rhinosinusitis. We tested whether the leukotriene receptor antagonist ONO-1078 (Pranukast) had steroid sparing effect on mode- rate to severe asthmatics with chronic rhinosinusitis. METHODS: Eighteen asthmatic patients with chronic rhinosinusitis who required more than 800 mcg/day of budesonide inhalation for the adequate control of asthma symptoms were recruited for this study. For the first 4 weeks, patients were treated with high dose (800-1200 mcg/day) budesonide inhalation. For the next 4 weeks, the dose of budesonide inhalation was decreased by 400 mcg/day and oral ONO-1078 (900mg/day) was administered. FEV1 was evaluated every 2 weeks, and PC20 on methacholine challenge, serum eosinophil cationic protein and blood eosinophil count were measured every 4 weeks. Diary cards were completed with morning and evening PEFR and symptom scores for asthma and rhinosinusitis during the treatment periods. RESULTS: Despite the reduction of the dose of inhaled corticosteroid by 400mcg/day, FEV1 and PEFR did not decrease with the addition of oral ONO-1078. The symptom scores of asthma and rhino-sinusitis did not change, and the need for beta2-agonist did not increase. CONCLUSION: These results suggest that ONO-1078 might have steroid sparing effect in moderate to severe persistent asthmatics with chronic rhinosinusitis who required high dose nhaled budesonide to control asthma symptoms.